'
RPG Life sciences hosted a conference
call on Nov 8, 2024. In the conference call, the company was represented by Mr Vishal
shah- CFO and Mr Yugal Sikri- Managing director.
Key takeaways
of the call
The overall performance of the company
continued to be strong. EBITDA margin retained its 5-year long upward
trajectory growing from 24.28% to record 26.67% YoY.
The exceptional items for the quarter
ending September 30, 2024, reflect a payment of Rs 27.3 crore made by the company
for transfer charges. This payment follows an order dated September 12, 2024,
from the Maharashtra Industrial Development Corporation (MIDC) in response to
the Company’s application under the amnesty scheme outlined in the Government
Resolution (GR) dated July 26, 2024.
Ashok Nair is appointed as new managing
director of the company with effect from January 7, 2025. He will assume office
of Managing...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
Targets revenue of Rs 1000 crore in FY24
-
Capex plan is US$ 30-32 million for next three years
|
|